462 related articles for article (PubMed ID: 38234088)
1. Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.
Suzuki K; Tamaki N; Kurosaki M; Takahashi Y; Yamazaki Y; Uchihara N; Tanaka Y; Miyamoto H; Yamada M; Keitoku T; Okada R; Higuchi M; Takaura K; Tanaka S; Maeyashiki C; Yasui Y; Tsuchiya K; Nakanishi H; Izumi N
Hepatol Res; 2024 Jan; ():. PubMed ID: 38234088
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performances of Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction-associated steatotic liver disease in Asian primary care clinics.
Park H; Kim M; Kim HL; Cho S; Yoon EL; Jun DW
Hepatol Res; 2024 May; ():. PubMed ID: 38703383
[TBL] [Abstract][Full Text] [Related]
3. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
4. Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysis.
Mori K; Akiyama Y; Tanaka M; Sato T; Endo K; Hosaka I; Hanawa N; Sakamoto N; Furuhashi M
J Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38629681
[TBL] [Abstract][Full Text] [Related]
5. Dietary characteristics associated with the risk of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease in non-obese Japanese participants: A cross-sectional study.
Taniguchi H; Ueda M; Sano F; Kobayashi Y; Shima T
JGH Open; 2024 May; 8(5):e13082. PubMed ID: 38779132
[TBL] [Abstract][Full Text] [Related]
6. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.
Wu T; Ye J; Mo S; Ye M; Li X; Li Q; Wang W; Zheng Q; Luo K; Zhang Y; Tu S; Che D; Gong R; Chen X; Miu R; Shao C; Sun Y; Zhong B
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38695344
[TBL] [Abstract][Full Text] [Related]
7. Exploring the landscape of steatotic liver disease in the general US population.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
[TBL] [Abstract][Full Text] [Related]
8. Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.
Wang SW; Hsieh TH; Cheng YM; Wang CC; Kao JH
Hepatol Int; 2024 Jun; 18(3):943-951. PubMed ID: 38227142
[TBL] [Abstract][Full Text] [Related]
9. Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.
Park HJ; Lee S; Lee JS
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38587630
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature.
Ma N; Bansal M; Chu J; Branch AD
J Pediatr Gastroenterol Nutr; 2024 May; ():. PubMed ID: 38693784
[TBL] [Abstract][Full Text] [Related]
11. New concept in fatty liver diseases.
Tokushige K
Hepatol Res; 2024 Feb; 54(2):125-130. PubMed ID: 38146790
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study.
Miwa T; Tajirika S; Imamura N; Adachi M; Horita R; Hanai T; Fukao T; Shimizu M; Yamamoto M
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398471
[TBL] [Abstract][Full Text] [Related]
13. Update in lean metabolic dysfunction-associated steatotic liver disease.
Sato-Espinoza K; Chotiprasidhi P; Huaman MR; Díaz-Ferrer J
World J Hepatol; 2024 Mar; 16(3):452-464. PubMed ID: 38577539
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
Iwaki M; Fujii H; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Tsutsumi T; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T
Clin Mol Hepatol; 2024 Apr; 30(2):225-234. PubMed ID: 38263684
[TBL] [Abstract][Full Text] [Related]
15. Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease.
Loomba R; Wong VW
Aliment Pharmacol Ther; 2024 Jan; 59(2):150-156. PubMed ID: 38153279
[TBL] [Abstract][Full Text] [Related]
16. National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.
Lee BP; Dodge JL; Terrault NA
Hepatology; 2024 Mar; 79(3):666-673. PubMed ID: 37732946
[TBL] [Abstract][Full Text] [Related]
17. Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.
Fukuda T; Okamoto T; Fukaishi T; Kawakami A; Tanaka M; Yamada T; Monzen K
Front Endocrinol (Lausanne); 2024; 15():1392280. PubMed ID: 38779448
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa.
Younossi ZM; Golabi P; Paik J; Owrangi S; Yilmaz Y; El-Kassas M; Alswat K; Alqahtani SA
Liver Int; 2024 Apr; 44(4):1061-1070. PubMed ID: 38305642
[TBL] [Abstract][Full Text] [Related]
19. Steatotic liver disease, MASLD and risk of chronic kidney disease.
Bilson J; Mantovani A; Byrne CD; Targher G
Diabetes Metab; 2024 Jan; 50(1):101506. PubMed ID: 38141808
[TBL] [Abstract][Full Text] [Related]
20. High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
Barritt AS; Yu F; Mospan AR; Newsome PN; Roden M; Morris HL; Loomba R; Neuschwander-Tetri BA;
Am J Gastroenterol; 2024 May; ():. PubMed ID: 38587293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
